Clinical and immunological factors associated with bullous pemphigoid relapse.
Division of Dermatology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee2Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee.
Jo-David
JD
Fine
D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens / Q000276:immunology*; D002352:Carrier Proteins; D003598:Cytoskeletal Proteins; D000071821:Dystonin; D005260:Female; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000276:immunology*; D009419:Nerve Tissue Proteins; D024041:Non-Fibrillar Collagens / Q000276:immunology*; D010391:Pemphigoid, Bullous / Q000276:immunology*; D000097805:Collagen Type XVII
D001323:Autoantibodies; D001324:Autoantigens; D002352:Carrier Proteins; D003598:Cytoskeletal Proteins; D000071821:Dystonin; D008562:Membrane Glycoproteins; D009419:Nerve Tissue Proteins; D024041:Non-Fibrillar Collagens; D000097805:Collagen Type XVII; C486268:DST protein, human